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Background: The Global Lung Function Initiative 2012 (GLI) reference values are currently endorsed by several
respiratory societies but evaluations of applicability for adults resident in European countries are lacking. The aim of
this study was to evaluate if the GLI reference values are appropriate for an adult Caucasian Swedish population.
Methods: During 2008–2013, clinical examinations including spirometry were performed on general population
samples in northern Sweden, in which 501 healthy Caucasian non-smokers were identified. Predicted GLI reference
values and Z-scores were calculated for each healthy non-smoking subject and the distributions and mean values
for FEV1, FVC and the FEV1/FVC ratio were examined. The prevalence of airway obstruction among these healthy
non-smokers was calculated based on the Lower Limit of normal (LLN) criterion (lower fifth percentile) for the FEV1/FVC
ratio. Thus, by definition, a prevalence of 5% was expected.
Results: The Z-scores for FEV1, FVC and FEV1/FVC were reasonably, although not perfectly, normally distributed,
but not centred on zero. Both predicted FEV1 and, in particular, FVC were lower compared to the observed values
in the sample. The deviations were greater among women compared to men. The prevalence of airway obstruction
based on the LLN criterion for the FEV1/FVC ratio was 9.4% among women and 2.7% among men.
Conclusions: The use of the GLI reference values may produce biased prevalence estimates of airway obstruction in Sweden,
especially among women. These results demonstrate the importance of validating the GLI reference values in different countries.
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Reference values for spirometry are necessary for identifying
subjects with abnormal lung function. The European Coal and
Steel Community (ECSC) reference values [1] have until re-
cently been recommended for European countries by the
European Respiratory Society (ERS). In Sweden, two domestic
reference values have been widely used [2-4]. In 2012, The
Global Lung Function Initiative (GLI), an ERS task force, pre-
sented new multi-ethnic reference values for spirometry [5] for
several different ethnicities within the three to 95 years age-
span. These GLI reference values are currently endorsed by
several respiratory societies [5,6]. For Caucasians, the GLI ref-
erence values are based on data from asymptomatic lifelong* Correspondence: eva.ronmark@nll.se
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unless otherwise stated.non-smokers from 30 different centres comprising 57,395 sub-
jects with European ancestry from several European countries
including Sweden, along with Israel, Australia, USA, Canada,
Brazil, Chile, Mexico, Uruguay, Venezuela, Algeria and Tunisia.
They have been evaluated and found to be applicable for the
Australasian population aged 4–80 years [7] as well as for
British children [8], but do not reflect data for Tunisian adults
very well [9]. Further evaluations of applicability from other
parts of the world are required in order to verify the appropri-
ateness in these areas. Hitherto, there are no publications
evaluating the applicability of the GLI reference values for
Caucasian adult residents in any of the European countries.
The definition of airway obstruction is based on the ratio
between forced expiratory volume in one second (FEV1) and
the vital capacity (VC) measured by slow (SVC) and/or
forced (FVC) manoeuvres. According to the Global Initiative
on Obstructive Lung Disease (GOLD) a post-bronchodilatoral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Characteristics of the reference population
Women 244 Men 257
Mean age ± SD
(range) in years
49.2 ± 17.6
(22.6-91.3)
46.6 ± 15.9
(22.7-86.7)
Mean height ± SD
(range) in cm
163.3 ± 6.7
(139–181)
178.9 ± 7.0
(162–198)
Mean weight ± SD
(range) in kg
68.2 ± 12.1
(45.0-118.0)
84.7 ± 13.5
(56.0-148.0)
Mean BMI ± SD
(range)
25.6 ± 4.2
(17.1-39.0)
26.4 ± 3.7
(18.9-44.1)
Mean FEV1 ± SD 2.88 ± 0.67 4.18 ± 0.78
Mean FVC ± SD 3.66 ± 0.81 5.30 ± 0.94
Mean SVC ± SD 3.71 ± 0.82 5.43 ± 0.94
Mean VC ± SD 3.73 ± 0.81 5.45 ± 0.94
Mean FEV1/FVC ± SD 0.785 ± 0.064 0.788 ± 0.056
Mean FEV1/VC ± SD 0.770 ± 0.067 0.766 ± 0.060
N = Number of subjects, SD = Standard Deviation, BMI = Body Mass Index,
FEV1 = Forced Expiratory Volume in one second, FVC = Forced Expiratory
Vital Capacity, SVC = Slow Expiratory Vital Capacity, VC = Vital Capacity; the
highest value of FVC and SVC. All variables except for age and the FEV1/FVC
and FEV1/VC ratios differed significantly between men and women.
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[10]. The ERS and American Thoracic Society (ATS) recom-
mend the use of Lower Limit of Normal (LLN) defined as
the lower fifth percentile of the distribution for healthy non-
smokers to define an abnormally low ratio [11-13]. The LLN
definition is dependent on the set of reference values in use.
Consequently, when implementing the LLN criteria in a
population of healthy non-smoking subjects, a prevalence of
obstruction of 5% indicates perfect applicability of the refer-
ence values in use.
It is of great importance that the population from
which the reference values are derived is representative
for the population under study. The age distribution and
other anthropometric, ethnic, environmental and socio-
economic factors should be equivalent since such factors
can affect lung function. Additionally, the methodology
for performing spirometric measurements in terms of
protocol and equipment etc. must be stringent [11,14].
The aim of the present study was to evaluate if the
GLI reference values, although endorsed by several respira-
tory societies including the ERS and ATS, are applicable
for an adult Caucasian population resident in Sweden.
Methods
Study design and reference population
The study sample was recruited from the Obstructive Lung
Disease in Northern Sweden (OLIN) Studies population-
based cohorts. In 2006, a randomly selected cohort in ages
20–69 years was invited to a postal questionnaire survey
(n = 7,997) together with a follow-up of a previously
recruited randomly selected cohort aged 30–84 years in
2006 (n = 7,004). Of the responders (n = 12,055, 80.4%),
1016 subjects were randomly selected after stratification
reflecting the age and sex distribution of the general popu-
lation in the study area. They were invited to examinations
including structured interviews and lung function tests in
which 726 subjects (71.5%) participated. In order to obtain
a sufficient number of healthy non-smokers, an additional
sample of 738 healthy non-smokers according to the 2006
questionnaire survey were also invited to the examinations
and 448 (60.7%) participated. All examinations were per-
formed during 2008–2013, and, in total, 501 Caucasians
(49% women) were identified as healthy non-smokers with
acceptable spirometry quality and constitute the reference
population.
Healthy non-smokers [15] were defined as subjects
without a history of any airway or lung disease, breathless-
ness, cough, wheeze, ischemic heart disease, rheumatic
disorders or a previous life-time exposure of > one
pack-year of smoking. Their characteristics are de-
scribed in Table 1. Eligibility criteria are presented in
an appendix [see Additional file 1]. The age was calcu-
lated by one decimal point as the difference between
date of birth and date of examination. Height wasmeasured in stocking feet with an accurate stadiometer
with 0.5 cm precision. Weight was measured with
0.5 kg precision without jacket and shoes and with
empty pockets. Written informed consent for participa-
tion in the study was obtained from the participants and
the study was approved by the Regional Ethical Review
Board at Umeå University, Sweden.
Spirometric measurements
Spirometric measurements included FEV1, FVC and
SVC performed on two Jaeger Masterscope spirometers
(JLAB version 5.21, CareFusion, Würzburg, Germany).
The spirometers were calibrated each morning, and a
minimum of three and a maximum of eight measure-
ments were performed per subject. The procedures
were performed without use of bronchodilators and fol-
lowing the ATS/ERS recommendations [16] but with a
repeatability criterion of ≤5% deviation from the second
highest value [17]. Once the data had been exported from
the spirometers to an electronic data file, data validity
controls were performed. The repeatability criterion was
not met for 2% of the measurements and each such
measurement was thoroughly examined by post-hoc
ocular control of flow-volume charts, resulting in the exclu-
sion of two subjects.
Statistical analysis
The GLI reference values are based on pre-bronchodilator
values, and only pre-bronchodilator values from the refer-
ence population were collected and analysed. Using the
Excel macro for GLI [18], reference values, lower limit of
normal (LLN), Z-scores and percentiles for FEV1, FVC
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ject in the reference population. The GLI Z-score is a
standardized measure of the positioning of an observed
measurement in the distribution of the population from
which the GLI reference values are derived and takes
both between-subject and age- and height-related vari-
ability into account. If the agreement between the
observed values in the reference population and the
GLI reference values is perfect, the mean Z-scores
should ideally be zero, and the standard deviation
(SD) should be one [19]. Mean values and standard
deviations were calculated, and Q-Q plots were scru-
tinized to determine if the Z-scores were normally
distributed. Possible relationships between Z-scores
and age, height, weight and sex were examined by
multiple linear regression models. If the GLI refer-
ence values are applicable, no such relationship
should exist. LLN was defined as the lower fifth
percentile in the distribution from which the GLI
reference values are derived, as calculated by the
GLI Excel macro, if not explicitly stated otherwise.
The 90% limits of normality, which are expected toTable 2 Mean GLI Z-scores for FEV1, FVC and the FEV1/FVC ra
FEV1
Age group Sex N Mean (SD) p-value
22-29 y Women 28 0.05 (0.92)
Men 32 −0.16 (0.80) 0.346
30-39 y Women 78 0.16 (0.89)
Men 86 0.17 (0.88) 0.937
40-49 y Women 39 0.25 (0.78)
Men 53 0.25 (0.98) 0.999
50-59 y Women 35 0.46 (0.96)
Men 31 0.29 (0.98) 0.464
60-69 y Women 21 0.20 (0.86)
Men 24 0.41 (1.04) 0.481
70-79 y Women 19 0.16 (0.88)
Men 17 0.68 (0.77) 0.071
80-91 y Women 24 0.07 (0.85)
Men 14 0.30 (0.85) 0.420
<40 y Women 106 0.13 (0.90)
Men 118 0.08 (0.87) 0.671
≥40 y Women 138 0.25 (0.86)
Men 139 0.34 (0.95) 0.415
All ages Women 244 0.20 (0.88)
Men 257 0.22 (0.92) 0.784
SD = standard deviation.
P-values for difference between sexes (independent samples T-test).
Bolded figures indicate p-values < 0.05 for difference between sexes.
GLI = Global Lung Function Initiative.
FEV1 = Forced Expiratory Volume in one second.
FVC = Forced Expiratory Vital Capacity.include 90% of the observations if the agreement is
perfect, were defined as observations with GLI Z-
scores within the −1.645 to +1.645 ranges. To iden-
tify the lower 2.5th percentile, the Z-score threshold
of −1.96 was used.
For comparison, a number of other commonly used
reference values were also applied on the reference
population, i.e. ECSC [1] and Hankinson [20], and from
Scandinavia, Berglund [2], Hedenström [3,4], Langhammer
[21], Gulsvik [22] and Viljanen [23]. Mean observed
measurements, expressed as percent of predicted, were
calculated across the different sets of reference values.
Results
The distribution of GLI Z-scores
When applying the GLI reference values [5] on the
reference population, the Z-scores for FEV1, FVC and
FEV1/FVC were reasonably, although not perfectly,
normally distributed, but not centred around zero. The
mean Z-score was 0.21 (SD 0.91) for FEV1, 0.35 (SD 0.92)
for FVC and −0.25 (SD 0.85) for the FEV1/FVC ratio
and differed significantly from zero for all threetio by age group and sex
FVC FEV1/FVC
Mean (SD) p-value Mean (SD) p-value
0.26 (0.97) −0.35 (0.83)
0.11 (0.84) 0.509 −0.41 (0.97) 0.818
0.49 (0.89) −0.56 (0.80)
0.28 (0.92) 0.143 −0.20 (0.81) 0.006
0.36 (0.82) −0.21 (0.89)
0.20 (0.95) 0.381 0.04 (0.80) 0.152
0.61 (1.05) −0.27 (0.98)
0.31 (1.04) 0.245 −0.04 (0.80) 0.310
0.43 (0.71) −0.44 (0.74)
0.41 (0.93) 0.939 −0.01 (0.88) 0.080
0.51 (1.12) −0.54 (0.94)
0.68 (0.87) 0.604 −0.02 (0.57) 0.051
0.07 (0.80) −0.10 (0.86)
0.38 (0.96) 0.292 −0.14 (0.68) 0.884
0.43 (0.91) −0.50 (0.81)
0.24 (0.90) 0.108 −0.26 (0.86) 0.030
0.41 (0.92) −0.29 (0.89)
0.34 (0.96) 0.542 −0.01 (0.77) 0.006
0.42 (0.91) −0.38 (0.86)
0.29 (0.93) 0.126 −0.12 (0.82) 0.001
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predicted values across all ages except for FEV1 among
22–29 year olds. The pattern was the opposite for the
FEV1/FVC ratio, where Z-scores generally were below
zero across all ages, in particular among women. Inde-
pendent samples T-tests showed a significant difference
in mean Z-scores between women and men for the
FEV1/FVC ratio, but not for FEV1 or FVC [Table 2].
Mean Z-scores deviated significantly from zero in
the same age groups as where mean percent of pre-
dicted significantly deviated from 100% as displayed in
Figures 1 and 2.Figure 1 Mean observed values of a) FEV1, b) FVC and c) FEV1/
FVC in percent of GLI reference values by age group, among
women. 95% Confidence Intervals for the difference between mean%
and 100% are displayed. An asterix (*) denotes p<0.05 for independent
samples T-test of difference compared to 100%.
Figure 2 Mean observed values of a) FEV1, b) FVC and c) FEV1/
FVC in percent of GLI reference values by age group, among men.
95% Confidence Intervals for the difference between mean% and 100%
are displayed. An asterix (*) denotes p<0.05 for independent samples
T-test of difference compared to 100%.For FEV1, 93.6% (94.3% among women, 93.0% among
men) of the 501 observations were within the 90%
limits of normality. For FVC, the corresponding pro-
portion was 90.2% (89.3% among women, 91.1% among
men), and for the FEV1/FVC ratio, the proportion was
92.2% (88.5% among women, 95.7% among men). How-
ever, only 2.0% of the women and 1.6% of the men had
FEV1/FVC values above the 95th percentile. The pat-
tern of Z-scores was the opposite for FEV1 and FVC.
For FEV1, 0.4% of the women and 1.2% of the men had
values below the 5th percentile, and 5.3% of the women
and 5.8% of the men above. For FVC, 0.8% of
the women and 1.2% of the men had values below the
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men above. The GLI percentile frequency distributions
for FEV1, FVC and the FEV1/FVC ratio were shifted,
particularly among women, towards higher percentiles
for FEV1 and FVC, and towards lower percentiles for
FEV1/FVC [Figure 3].Figure 3 Normal distribution curves of a) FVC, b) FEV1 and c)
FEV1/FVC based on observed GLI Z-score means and standard
deviations among women. The figures illustrate observed values of
Z-score mean and standard deviations (SD) among women.
LLN=Lower Limit of Normal. X=proportion of subjects with values
below LLN. Observed values of X are 0.4% for FEV1 (n=1), 0.8% for
FVC (n=2) and 9.4% for FEV1/FVC (n=23).Factors related to GLI Z-scores
When analysing the Z-scores for FEV1, FVC and the
FEV1/FVC ratio in relation to age, height, weight and
sex, small but statistically significant associations yielding
R-square values of 1-2% were found. Sex had a signifi-
cant impact on the Z-score for the FEV1/FVC ratio
(Beta-coefficient 0.256 (p = 0.001)), sex and height had a
significant impact on the Z-score for FEV1 (Beta-coefficient
0.276 (p = 0.023) for sex, −0.016 (p = 0.005) for height),
and weight had a significant impact on the FVC Z-score
(Beta-coefficient −0.009 (p = 0.001)).
Prevalence of airway obstruction according to LLN based
on GLI reference values
The prevalence of spirometrically defined airway obstruc-
tion in the reference population according to LLN for
the FEV1/FVC ratio was 9.4% (95% CI 5.7%-13.1%)
among women and 2.7% (95% CI 0.7%-4.7%) among men
(p-value = 0.002). When applying the lower 2.5th GLI
percentile as LLN; the prevalence of obstruction in the
reference population was 3.4% (95% CI 1.1%-5.7%) among
women and 1.5% (95% CI 0.0%-3.0%) among men.
Figure 4. illustrates that subjects defined as having
obstruction according to the LLN criterion tended to
have Z-scores for FEV1 below rather than above zero
and Z-scores for FVC above rather than below zero.
Comparison to other reference values
When other sets of reference values were applied
to the reference population, the mean FEV1
and FVC as percent of predicted significantly exceed
100% for both sexes according to ECSC, Hankinson
and Berglund. Mean FEV1 and FVC as percent of
predicted for reference values Hedenström (Sweden),
Langhammer (Norway), Gulsvik (Norway) and Viljanen
(Finland) were closer to 100%. In general, the FVC per-
cent of predicted values were more overestimated than
the FEV1 values for all sets of reference values, and
particularly so among women. Consequently, FEV1/
FVC and FEV1/VC as percent of predicted were gener-
ally below 100%, and more pronounced so among
women compared to men [Figure 5].
Discussion
Compared to the ECSC reference values, the GLI refer-
ence values are superior, but not perfect, for Swedish
adults. The original intention of GLI was that the same
reference values should be possible to use in most parts
of the world, covering different ethnicities and ages
to avoid age-related junction points between different
sets of reference values. The data which the GLI
equations are based on were collected from 1978 to
2008, which may question whether or not the oldest
data still are valid. However, earlier studies by
Figure 4 GLI Z-scores for a) FEV1/FVC, b) FEV1 and c) FVC among healthy non-smoking subjects with and without airway obstruction, by age.
Airway obstruction was defined according to the Lower Limit of Normal criterion (below 5th percentile) for the FEV1/FVC ratio based on the GLI reference values.
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trends in FEV1, FVC or FEV1/FVC in Caucasians during
the last 30 years. They also found that reference equations
derived from collated datasets, such as the GLI, are applic-
able across different centres using different equipment,
which is another strong argument for using GLI [24].
The GLI reference values represent the average of all avail-
able data they are based on and may thus not be representa-
tive for every specific subpopulation included. Since there
are substantial differences in e.g. occupational exposures
and environmental pollution which may affect lung function
between countries and regions populated by Caucasians,
differences in lung function can be expected. Data from
Swedish centres are included in the reference data from
which the GLI reference values are derived, but comprise
only 123 subjects. Since there are substantial differences in
anthropometric, environmental and socio-economic factors
between e.g. Scandinavia and southern Europe, an evalu-
ation of the fit for Swedish subjects is required.
Swanney et al. [25] argues that adopting the GLI reference
values in clinical practice worldwide is essential and urgent,
in order to reduce the confusion regarding which reference
values to rely on. In essence, Swanney et al. argues that
the use of GLI worldwide is preferable to local specific refer-
ence values obtained with different techniques, especially
since the GLI reference values have been evaluated and con-
sidered applicable for both Caucasian adults and children
[7,8]. Similar matters have also been argued previously by
Stanojevic et al. [14]. However, despite the fact that the GLI
reference values may be applicable for Caucasian popula-
tions in several countries, the present findings demonstrate
that there are differences between countries that have to be
considered.
The OLIN-studies have conducted research about
obstructive lung disease in Northern Sweden since 1985[26] and the research staff carrying out the spirometric mea-
surements are highly experienced. The sampling of the ref-
erence population was rigorously thorough, as was the data
quality and repeatability control. The reference population
originates from randomly selected healthy non-smokers of
the general population of Norrbotten, the northernmost
province of Sweden. Selection bias such as using health
personnel [2], employees within certain industries [1,2,23] or
subjects visiting a certain clinic is thus avoided. One of the
strengths of this study is that data is contemporary, i.e. col-
lected from 2008 to 2013, and thus possible secular trends
in this data set can be ruled out. It has previously been
shown that 150 subjects of each sex is a sufficient sample
size to make a reliable evaluation of the applicability of refer-
ence values for spirometry [24], and hence this evaluation
can be considered convincingly reliable. A possible weakness
of this study is that no data of cotinine levels were analysed
to confirm non-smoking.
This Swedish study showed a positive offset for
observed FEV1 and FVC compared to the GLI reference
values, with mean Z-scores for FEV1 and FVC above the
expected for both sexes and across almost all ages. Mean
values of FEV1 and, in particular, FVC as percent of pre-
dicted values exceeded 100% to a greater extent among
women than among men. In this study, FVC as percent of
predicted value exceeded 100% also according to most of
the reference values from other areas, i.e. reference values
ECSC [1], Hankinson [20], Langhammer [21] and Gulsvik
[22]. The GLI reference values yield similar results as
Hankinson’s, with percent of predicted values closer to
100% compared to the previously recommended ECSC
reference values, in line with results from previous studies
[6]. Reference values from Sweden [3,4] and Finland
[23] yielded mean percent of predicted values closer to
100%. However, recent debate criticise the use of percent
Figure 5 Mean values of a) FEV1, b) FVC and c) the Ratio
expressed as percent of predicted according to different
reference values, by sex. Mean percent of predicted values are
displayed for FEV1, FVC and the FEV1/FVC and FEV1/VC ratios
based on data from a population-based sample of healthy
non-smoking subjects. The age-span included is 22 to 65 years
(n=192 women and n=218 men) in which all reference values can
be applied without extrapolation. GLI=Global Lung Initiative 2012,
ECSC=European Coal and Steel Community. *p-value<0.05
(one-sample T-test compared to 100%). ¤ Berglund reference
values for FVC represent VC; i.e. the best of FVC and SVC.
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bedded in this measure, and advocates the use of Z-scores
instead [6,27].
The standard deviations for FEV1 and FVC Z-
scores were close to 0.9 for both sexes, implying that
the dispersion around the mean was lower in this
sample compared to the GLI. Consequently the LLN
for these values may be “too low”. Almost 10% of
the subjects were outside the 90% limits of normality
as defined by GLI (6.4% for FEV1, 9.8% for FVC),but most of those subjects were located above
the 95th percentile. The authors of the study which
evaluated the applicability of GLI on an Australasian
population argue that Z-score deviations <0.5 (corre-
sponding to <3% deviations) are clinically insignifi-
cant [7]. In this study however, the deviation of 0.42
Z-scores for FVC among women represent a devi-
ation of 6%. The classification into severity grades of
airway and lung disease often relies on FEV1 or FVC
as percent of a reference value, and thus the use
of GLI may lead to invalid classification of disease
severity in Sweden.
The mean predicted FEV1/FVC ratio was higher
compared to the mean observed ratio, and more
pronounced so among women compared to men. The
Z-score SD’s for both sexes were consistently below
0.9 for the ratio, implying a lower variability in this
Swedish dataset also for the ratio. Since the spiromet-
ric definition of airway obstruction relies on the ratio,
the fact that the GLI predicted ratios are higher means
that the prevalence of obstruction may be overesti-
mated in Sweden. Additionally, since the dispersion
around the ratio is lower in Sweden compared to GLI,
use of the GLI LLN criteria may overestimate the
prevalence of obstruction even further. LLN will by
definition allow for a 1/20 false positive rate, and this
study clearly illustrates that among healthy subjects,
those identified as obstructive by the LLN criterion in
particular are those with high FVC values.
Regardless of criteria for airway obstruction, the preva-
lence was higher among women than men in the reference
population. If the agreement with GLI is perfect, no such
sex-difference should exist when applying the LLN criteria
of obstruction based on the GLI reference values. In this
study, 9.4% of the women were identified as obstructive
according to the GLI LLN criterion (fifth percentile),
which indicates that this criterion may overestimate the
prevalence of airway obstruction in Swedish women.Conclusions
In conclusion; the GLI reference values are preferable
compared to the ECSC for Swedish adults. However,
among non-smoking healthy men and women in north-
ern Sweden, the mean values of FEV1 were somewhat
larger compared to those in the non-smoking healthy
GLI reference population. A greater discrepancy was
found for FVC, especially among women. The use of the
LLN criterion for airway obstruction based on the GLI
reference values for the FEV1/FVC ratio may produce
biased prevalence estimates of airway obstruction in
Sweden, in particular among women. These results dem-
onstrate the importance of validating the GLI reference
values in different countries.
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